Brief: Biosyent Announces The Availability Of Tibella® In Canada
29/07/2020 21:19
July 29 (Reuters) - Biosyent Inc RX.V :
* BIOSYENT ANNOUNCES THE AVAILABILITY OF TIBELLA® (TIBOLONE)
IN
CANADA
Source text for Eikon: ID:nGNX2dNSHv
Further company coverage: RX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biosyent
See all newsCanada's BioSyent Q2 revenue jumps 95% following Oral Health acquisition
Canada's BioSyent Q1 revenue rises helped by Oral Science acquisition
Brief: Biosyent Announces Closing Of The Acquisition Of Oral Science Inc.
Brief: Biosyent To Acquire Oral Science Inc.
Brief: Biosyent Announces Renewal Of Normal Course Issuer Bid